News Daily News Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding L.A. McKeown May 16, 2025
News Daily News Patchy Anticoagulation Use During COVID Pandemic Raises Questions L.A. McKeown March 06, 2025
News Daily News IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication L.A. McKeown December 03, 2024
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Daily News Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE Todd Neale October 19, 2022
News Daily News Shorter Anticoagulation an Option for Young Patients With Provoked VTE Todd Neale January 11, 2022
News Daily News Long-term Anticoagulation After Unprovoked VTE: New Insights Shelley Wood September 13, 2021
News Daily News VTE Related to SARS-CoV-2 Infection Less of a Problem in Outpatients Todd Neale April 06, 2021
News Daily News In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate Yael L. Maxwell July 21, 2020
News Daily News Interventional Options and Future Directions for Acute PE: New AHA Statement Todd Neale October 07, 2019
News Daily News Catheter-Directed Thrombolysis for DVT Increases Bleeding Compared With Standard Anticoagulation L.A. McKeown July 24, 2014
News Daily News Single-Center Studies Build Case for Venous Angioplasty in Multiple Sclerosis Caitlin E. Cox April 05, 2012